A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency
Clinical trial NCT01495910 · COMPLETED
Trial details
- NCT number
- NCT01495910
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-02-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.